Memantine and donepezil hydrochlorides
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Memantine and Donepezil Hydrochlorides is a prescription extended-release capsule combining two medications to help manage symptoms of Alzheimer's disease. Donepezil (10 mg) inhibits cholinesterase to improve memory and thinking, while memantine (21 mg) blocks NMDA receptors to protect brain cells. Taken orally once daily, it's manufactured by ANI Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Memantine and donepezil hydrochlorides
Access the FDA dataset for Memantine and donepezil hydrochlorides โ ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025